Phospho-Insulin Receptor (Tyr1185) Antibody [D6L11]

N° de catalogue F3837

Imprimer

Description biologique

Spécificité Phospho-Insulin Receptor (Tyr1185) Antibody [D6L11] détecte les niveaux endogènes de la protéine du récepteur de l'insuline uniquement lorsqu'elle est phosphorylée en Tyr 1185.
Contexte Le récepteur de l'insuline (IR) est une Protein Tyrosine Kinase cruciale pour la médiation des effets pléiotropes de l'insuline sur le métabolisme et la croissance. Son domaine kinase intracellulaire contient une boucle d'activation (boucle A) avec des résidus tyrosine clés, Tyr1158, Tyr1162 et Tyr1163, dont la phosphorylation déclenche des changements de conformation qui activent pleinement la kinase. La phosphorylation de Tyr1185 stabilise la conformation active de la boucle A, permettant un accès sans entrave à l'ATP et aux peptides substrats, ce qui permet une phosphorylation efficace du substrat. Cette autophosphorylation est un processus graduel où chaque tyrosine phosphorylée stabilise de manière incrémentielle la conformation active, assurant une régulation stricte. Le groupe phosphate sur Tyr1185 sert d'interrupteur moléculaire critique, favorisant les réarrangements structurels qui font passer la kinase d'un état auto-inhibé à un état actif. Les tyrosines phosphorylées de la boucle A, y compris Tyr1185, créent des sites d'ancrage pour les protéines de signalisation en aval telles que l'IRS (substrat du récepteur de l'insuline), intégrant l'activation du récepteur avec les voies cellulaires, y compris les cascades PI3K/Akt et MAPK qui régulent l'absorption du glucose, le métabolisme et l'expression génique. La dérégulation de la phosphorylation de l'IR altère la signalisation de l'insuline et est impliquée dans l'insulinorésistance et le diabète de type 2.

Informations dutilisation

Application WB, IP Dilution
WB IP
1:2000 1:20
Réactivité Human
Source Rabbit Monoclonal Antibody MW 156 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:2000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Références

  • https://pubmed.ncbi.nlm.nih.gov/37001136/
  • https://pubmed.ncbi.nlm.nih.gov/9312016/

Données dapplication

WB

Validé par Selleck

  • F3837-wb
    Lane 1: HepG2, Lane 2: HepG2 (Insulin treated)